Cotrimoxazole and Digoxin Interaction
Trimethoprim in cotrimoxazole increases serum digoxin levels, particularly in elderly patients, requiring dose reduction of digoxin and close monitoring when these drugs must be used together.
Mechanism and Clinical Significance
Cotrimoxazole (trimethoprim-sulfamethoxazole) interacts with digoxin through inhibition of renal tubular secretion of digoxin by the trimethoprim component 1. The FDA drug label explicitly warns that increased digoxin blood levels can occur with concomitant therapy, especially in elderly patients 2.
The clinical impact is substantial:
- 22% increase in serum digoxin levels has been documented in elderly patients (median age 78 years) on stable digoxin doses 1
- A recent large population study found a 5.71-fold increased risk of hospital encounters for digoxin toxicity within 30 days when cotrimoxazole was co-prescribed versus amoxicillin (absolute risk increase 0.39%, NNH 256) 3
- The interaction is most pronounced in elderly patients due to age-related decline in renal function 2
Management Algorithm
First-Line Approach: Avoid the Combination
Prescribe an alternative antibiotic when clinically appropriate 3. Consider amoxicillin or other non-interacting antibiotics based on the infection being treated.
If Cotrimoxazole Must Be Used:
Reduce digoxin dose before initiating cotrimoxazole 4
- The ACC/AHA heart failure guidelines specifically list cotrimoxazole among drugs requiring digoxin dose reduction when co-administered 4
Monitor serum digoxin levels 2
- Check levels before starting cotrimoxazole
- Recheck within 3-5 days of starting cotrimoxazole
- Target therapeutic range: 0.5-0.9 ng/mL (lower end preferred) 4
Monitor for digoxin toxicity symptoms:
- Cardiac: arrhythmias (ectopic beats, heart block, ventricular tachycardia)
- Gastrointestinal: anorexia, nausea, vomiting
- Neurological: visual disturbances, confusion, disorientation 4
Monitor serum potassium closely 2
- Both drugs can cause hyperkalemia
- Hypokalemia potentiates digoxin toxicity even at lower serum levels 4
High-Risk Populations Requiring Extra Vigilance
- Age >70 years 4, 2
- Impaired renal function 4
- Low lean body mass 4
- Concurrent thiazide diuretics (increased thrombocytopenia risk) 2
Critical Pitfalls to Avoid
Do not assume the interaction is clinically insignificant. While the absolute risk increase is modest (0.4%), the nearly 6-fold relative risk increase in a medication with a narrow therapeutic index makes this a serious drug-drug interaction 3.
Do not rely solely on digoxin levels. Toxicity can occur at therapeutic or even low levels when hypokalemia, hypomagnesemia, or hypothyroidism coexist 4.
Do not forget to adjust digoxin back up after completing the cotrimoxazole course, or the patient may lose therapeutic benefit.
The British Thoracic Society guidelines for NTM disease also list this interaction, noting that "trimethoprim may increase serum digoxin levels in some elderly people" 5, reinforcing the need for monitoring across different clinical contexts.